HOLLISTON, Mass.–Harvard Bioscience, Inc. (Nasdaq: HBIO – News), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research, today announced the hiring and appointment of Thomas McNaughton as its new Chief Financial Officer effective immediately.

Mr. McNaughton most recently served as Chief Financial Officer for Tivoli Audio, LLC a venture capital-backed global manufacturer of premium audio systems. Prior to joining Tivoli, Mr. McNaughton spent 14 years at Cabot Corporation (NYSE: CBT – News) where he most recently held the position of Chief Financial Officer of Cabot Supermetals, a $350 million Cabot Corporation division that provides high purity tantalum and niobium products to the electronics and semiconductor industries. Prior to serving as Chief Financial Officer of this division, Mr. McNaughton held various finance positions of increasing responsibility including financial reporting, treasury, investor relations and acquisitions within Cabot Corporation. Mr. McNaughton began his career at Deloitte & Touche, LLP, and practiced for eight years as a Certified Public Accountant in the audit services group.

“We are very pleased to have Tom join our team”, said Chane Graziano, Chief Executive Officer. “Tom’s background and experience are a perfect fit for Harvard Bioscience and will provide great value that will assist us in achieving our long-term growth objectives.”